Zcash Prepares for NU7 Upgrade as Zebra Gets Key Security Fixes 
Oil Prices Fall as Middle East Exports Recover, G7 Eases Supply Fears 
UK House Prices Flat in September as Mortgage Rates Weigh 
Kalshi Withdraws PEPE Perpetual Futures Filing 
Anthropic Expands Claude Access for Cyber Defense Teams 
Australia Consumer Confidence Plunges as RBA Rate Hike Hits Households 
Sanofi, Regeneron Expand Drug Partnership in $8 Billion Deal 
Japan Real Wages Rise 1.5%, Supporting BOJ Rate Hikes 
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial 
European Stocks Diverge as French Fiscal Crisis Hits CAC 40 
Asian Stocks Rise as Nasdaq Record Offsets Bond Yield Pressure 
Robinhood Buys $25 Million in Bitcoin for Corporate Treasury 
Iceland 4x4 Rental Guide: When Do You Really Need Four-Wheel Drive? 
European Stocks Fall as Oil Rises Ahead of Fed Minutes 
China Shuts 670 Banks as Bitcoin Eyes Financial Risks 
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 
German Industrial Orders Plunge 10.6% in August 
Add as a preferred source on Google
Drugmakers including Pfizer Inc, GlaxoSmithKline PLC , Bristol Myers Squibb, AstraZeneca PLC and Sanofi SA will raise prices in the US on over 350 unique drugs in early January.
The increases are in preparation for the Inflation Reduction Act (IRA), which allows the government's Medicare health program to negotiate prices for some drugs starting in 2026.
The pharmaceutical industry is also dealing with inflation and supply chain constraints that increased manufacturing costs.
The price hikes are based on list prices, which do not account for other discounts or rebates to pharmacy benefit managers.
According to data released by 46brooklyn, a drug pricing non-profit affiliated with 3 Axis, drugmakers increased prices on more than 1,400 pharmaceuticals in 2022. Since 2015, there have been the most rises.
According to Antonio Ciaccia, president of 3 Axis, drugmakers have concentrated on releasing their medications at higher prices due to the concentration on annual price hikes.
More drug prices are likely to be announced over the course of January - historically the biggest month for drugmakers to raise prices.
Pfizer has so far disclosed the biggest price hikes, with 89 different prescription names seeing a rise in price in addition to an extra 10 drug brands at its Hospira division.
Then came GSK, which has already announced hikes for 26 different medications, including nearly a 7% rise for its well-known shingles vaccine Shingrix.
